BCL2L1 and leukemia: In summary, we have identified in the IS21 compound a pan ligand for Bcl-2, Bcl-xL and Mcl-1 anti-apoptotic members, which exhibits potent in vitro and in vivo efficacy against human leukemia and melanoma cancer models, offering the potential for further preclinical investigation.